MARIA VOUTSINA-KERNY: Open Payments
NPI 1902210628 · SEYMOUR, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 14 payments from 6 companies in 2025. Trend: 2023 $280 · 2024 $533 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $98 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $80 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| ABBVIE INC. | 1 | $27 |
| Dexcom, Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
Products named: CAPLYTA, Rybelsus, Ozempic, QULIPTA, Dexcom G6 Transmitter, GVOKE HYPOPEN, SHINGRIX, TRELEGY ELLIPTA.
Industry payments across TN — which companies pay providers there.
